ALM vs ARIS

ALM's deterministic health scores signal severe financial distress: the Piotroski F-Score of 1/9 indicates extreme weakness in operational and financial health, while the absence of an Altman Z-Score raises unquantified bankruptcy risk. Despite strong revenue growth (28% YoY) and a bullish analyst consensus (strong_buy), the company reports a negative profit margin (-216.27%), negative ROE (-57.31%), and negative earnings, rendering valuation metrics like Forward P/E (87.79) and Price/Book (31.95) meaningless. The stock trades at a massive premium to its fundamentals, with no intrinsic value or Graham Number available, suggesting speculative pricing. Insider activity is neutral, and the recent 20.2% one-week decline underscores high volatility and potential overvaluation.

ARIS exhibits a stable financial health profile with a Piotroski F-Score of 4/9 and a strong balance sheet characterized by low debt/equity (0.36). While the company is delivering explosive triple-digit growth in revenue (104.2%) and earnings (121.7%), the stock is significantly overvalued, trading at $18.76 against a Graham Number of $8.06 and an Intrinsic Value of $12.09. The combination of a bearish technical trend (0/100) and a high P/E ratio suggests that the market has already priced in much of the future growth, creating a high-risk entry point despite strong fundamentals.